Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma
Study sponsor: LianBio LLC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-05-31Actual
Enrollment · participants6Actual
Source updated2024-08-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.